CAAS Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-300
Closed -$37.9K 567
2024
Q4
$37.9K Buy
+300
New +$44.6K 0.01% 326
2024
Q3
Sell
-1,300
Closed -$173K 462
2024
Q2
$173K Sell
1,300
-3,200
-71% -$385K 0.06% 156
2024
Q1
$473K Buy
4,500
+2,300
+105% +$207K 0.03% 320
2023
Q4
$166K Buy
+2,200
New +$139K 0.02% 357
2023
Q3
Sell
-5,700
Closed -$464K 806
2023
Q2
$464K Buy
+5,700
New +$406K 0.03% 395

Other funds holding THC

CAAS Capital Management's THC Position: Q1 2025 in Review

CAAS Capital Management sold out of Tenet Healthcare (THC) in Q1 2025, closing a stake of 780 shares — an estimated $98.5K sold.

CAAS Capital Management first reported a position in THC in Q1 2021 and held it in 2 quarters. The position peaked at $5.18M in Q1 2021. 566 funds tracked by Wall St. Rank hold THC as of Q1 2025.

  • CAAS Capital Management reported no remaining Tenet Healthcare position as of Q1 2025 after selling out during the quarter.
  • CAAS Capital Management sold 780 Tenet Healthcare shares in Q1 2025, an estimated $98.5K.
  • CAAS Capital Management first reported a position in Tenet Healthcare in Q1 2021 and held it in 2 quarters.
  • CAAS Capital Management's Tenet Healthcare position peaked at $5.18M in Q1 2021.
  • 566 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2025.

Based on CAAS Capital Management's 13F filing for Q1 2025, filed 1 May 2025.